Deeply cleanses and removes impurities
General approach: If on Semaglutide 0.5 mg or less: Start tirzepatide at 2.5 mg If on Semaglutide 1.0 mg: Start tirzepatide at 5 mg If on Semaglutide 1.7-2.4 mg: Start tirzepatide at 5-7.5 mg Some providers start everyone at 2.5 mg regardless of previous dose to minimize side effects
Br J Ophthalmol 96(3):375379 Group OCTS-SCfNIIHS et al (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features
This is largely owing to trial variability, incorporation of trials with smaller scale trials reporting on MI rates [44, 47, 48, 51, 52, 59], the heterogeneity of the study population, and incorporation of zero total event trials in the current analysis [47, 48, 51, 52, 59]
The ASCO 2026 data does not support starting a GLP-1 medication in someone at a healthy weight for cancer prevention alone
In addition, it is possible that there will be further legislation or regulation that could harm the business, financial condition and results of operations